Department of Military Affairs Tender by Indian Army (GEM/2025/B/6184442)

13 point 9 pct eflornithine cream 15g tube,dutasteride 0 point 5mg tab,finasteride 5 mg tab,l ornit

Goods
Qty:5.6L
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6184442)

Tender Timeline

Tender Issue
April 30, 2025 at 10:25 AM

Tender Title:

Drugs and Consumables 02
Reference Number: GEM/2025/B/6184442

Issuing Authority/Department:

Department of Military Affairs
Ministry of Defence

Scope of Work and Objectives:

The purpose of this tender is to procure a variety of essential drugs and consumables, ensuring that the armed forces have access to the necessary medical supplies. The bid encompasses a total quantity of 563,493 items, including:

  • Eflornithine cream 15g tube
  • Dutasteride 0.5mg tablets
  • Finasteride 5mg tablets
  • Tobramycin 0.3% solution (5ml bottle)
  • Cinnarizine 25mg tablets
  • Clotrimazole ear drops

The objective is to select a competent supplier who can deliver high-quality pharmaceutical products in a timely and efficient manner.

Eligibility Criteria:

Participation in this tender is limited to registered entities that meet the following eligibility requirements:

  • Valid registration with relevant authorities.
  • Proven experience and a good track record in supplying pharmaceuticals.
  • Compliance with government procurement regulations.

Technical Requirements:

Bidders must demonstrate their capacity to supply the specified drugs and consumables while adhering to the highest quality standards. This includes:

  • Compliance with the latest healthcare regulations.
  • Ability to provide certifications for all products as required by the Ministry of Defence.
  • Potential bidders must be able to provide adequate testing reports to validate the quality of their pharmaceuticals.

Financial Requirements:

Bidders are expected to provide:

  • Comprehensive financial statements reflecting the last three years of operations.
  • Proof of availability of funds to ensure procurement capabilities.
  • Compliance with any additional financial security requirements as stipulated by the Department of Military Affairs.

Document Submission Details:

Interested parties must prepare and submit their documents electronically through the appropriate governmental bidding platform. All required documentation, including technical and financial proposals, must be formatted correctly and submitted within the specified timeline.

Special Provisions:

The tender may offer special provisions for Micro, Small, and Medium Enterprises (MSEs) and startups. This encourages local businesses to participate in government procurement, aligning with the national initiative to boost small-scale industries.

Evaluation Process:

Submissions will undergo a thorough evaluation process, which will include:

  • Verification of eligibility criteria.
  • Technical evaluation based on quality standards and compliance with specifications.
  • Financial analysis to assess pricing and bid competitiveness.

Delivery Locations:

Successful bidders will be required to deliver products to designated military establishments across multiple locations. Detailed delivery instructions will be provided in the tender documentation upon qualification.

Contact Information:

For inquiries regarding the tender, please refer to the designated contact points on the official government portal, ensuring that all communication follows the protocol outlined.

In conclusion, this tender represents a significant opportunity for suppliers in the pharmaceuticals sector to engage with the Ministry of Defence, ensuring that the armed forces are adequately supplied with essential medical products. Interested bidders are encouraged to carefully review all requirements and submit their proposals accordingly to participate in this vital procurement process.

Tender BOQ Items

34 Items
11392.

13 point 9 pct eflornithine cream 15g tube

Qty:60
Unit:tube
30
11503.

dutasteride 0 point 5mg tab

Qty:125040
Unit:no
30
12694.

finasteride 5 mg tab

Qty:8988
Unit:no
30
11603.

l ornithine l asparate 5 gm power

l ornithine l asparate 5 gm power sachet hepamerz sachet

Qty:3080
Unit:no
30
11627.

entacavir 0 point 5 mg tab

Qty:3872
Unit:no
30
11671.

mebeverine hcl 135mg tab

Qty:9228
Unit:no
30
11682.

paraffin liquid in bottle of 100 ml

Qty:180
Unit:bott
30
11770.

glipizide 5mg tab

Qty:850
Unit:no
30
11903.

tab solifenacin 5 mg

Qty:12720
Unit:no
30
12009.

ciprofloxacin hcl

ciprofloxacin hcl 0 point3 pct plus dexamethasone 0 point 1 pct bott of 5ml

Qty:850
Unit:bott
30
12044.

sodium chromoglycate eye drop

sodium chromoglycate eye drops 2 pct bott of 5 ml

Qty:1272
Unit:bott
30
12053.

timolol maleate eye drop

timolol maleate eye drop 0point 5 pct bott of 5 ml

Qty:1680
Unit:bott
30
12054.

tobramycin 0 point 3 bott of 5 ml

Qty:780
Unit:bott
30
12115.

cinnarizine 25 mg tab

Qty:90030
Unit:no
30
12122.

ear drops clotrimazole

ear drops clotrimazole 1 pct ear drop bott of 10ml

Qty:1242
Unit:bott
30
12145.

nasal drop xylometazoline hcl

nasal drop xylometazoline hcl 0 point 05 pct for paed use

Qty:1134
Unit:bott
30
12301.

alprazolam 0 point 25mg tab

Qty:79000
Unit:no
30
12353.

aripiprazole 10 mg tab

Qty:9175
Unit:no
30
12374.

tianeptine 12 point 5 mg, tab

Qty:1680
Unit:no
30
12375.

tab paroxetine xr 12 point 5mg

tab paroxetine xr 12.5mg

Qty:45000
Unit:no
30
12670.

cilostazole tab 100 mg

Qty:7320
Unit:no
30
12687.

tolterodine tartrate 2 mg tab

Qty:7000
Unit:no
30
12714.

iron syp with vitamins each 5 ml

Qty:4836
Unit:bott
30
12946.

tab leflunamide 10mg

Qty:17340
Unit:no
30
12952.

inj methotrexate 15 mg 1ml

Qty:24
Unit:vial
30
13261.

sulphamethoxazole 400 mg and trimethoprim 80mg

sulphamethoxazole 400 mg and trimethoprim 80mg tab septran

Qty:3570
Unit:no
30
13296.

zidovudine 300 mg tab

Qty:3990
Unit:no
30
13917.

tab methotrexate 15mg

Qty:2154
Unit:no
30
13924.

tab paroxetine 25 mg

Qty:15840
Unit:no
30
13925.

tab baclofen xl 30 mg

Qty:4590
Unit:no
30
14102.

mdi fluticasone propionate plus formoterol 120 mdi

Qty:240
Unit:no
30
14402.

tab dienogest 2 mg

Qty:240
Unit:no
30
16111.

tab olmesartan 20mg

Qty:70848
Unit:no
30
16113.

tab propranolol 10 mg

Qty:29640
Unit:no
30

General Information

Item Category
13 point 9 pct eflornithine cream 15g tube , dutasteride 0 point 5mg tab , finasteride 5 mg tab , l ornithine l asparate 5 gm power , entacavir 0 point 5 mg tab , mebeverine hcl 135mg tab , paraffin liquid in bottle of 100 ml , glipizide 5mg tab , tab solifenacin 5 mg , ciprofloxacin hcl , sodium chromoglycate eye drop , timolol maleate eye drop , tobramycin 0 point 3 bott of 5 ml , cinnarizine 25 mg tab , ear drops clotrimazole , nasal drop xylometazoline hcl , alprazolam 0 point 25mg tab , aripiprazole 10 mg tab , tianeptine 12 point 5 mg, tab , tab paroxetine xr 12 point 5mg , cilostazole tab 100 mg , tolterodine tartrate 2 mg tab , iron syp with vitamins each 5 ml , tab leflunamide 10mg , inj methotrexate 15 mg 1ml , sulphamethoxazole 400 mg and trimethoprim 80mg , zidovudine 300 mg tab , tab methotrexate 15mg , tab paroxetine 25 mg , tab baclofen xl 30 mg , mdi fluticasone propionate plus formoterol 120 mdi , tab dienogest 2 mg , tab olmesartan 20mg , tab propranolol 10 mg
Ministry Name
Organisation Name
City

Financial Information

Bid Offer Validity
180 (Days)
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7788871.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Nintedanib 100 mg Soft gelatin cap,Tab Acarbose 25 mg,Tab Telmisartan 20 mg,Carvedilol 6 point 25 m

₹1,450.00
GEM
Goods
Qty:14.1L
5 Files
Indian Army
KOLKATA, WEST BENGAL
Boq › Boql
Nintedanib 100 mg Soft gelatin cap , Tab Acarbose 25 mg , Tab Telmisartan 20 mg , Carvedilol 6 point 25 mg Tab , Tab TRANEXAMIC ACID 250 mg , Tab Chlorthalidone 12 point 5 mg , Cilastazole 50 mg Tab , Tab Cilostazole 100 mg , Tab Danazol 100 mg , Anastrozole 1mg Tab , Cyclosporine A micro emulsion 25 mg Cap , Tab Leflunomide 10 mg , Tab Cinnarizine 25 mg , Tab Betahistine 16 mg , Fluvoxamine 50 mg Cap , Isoniazid 300 mg Tab , Gycerl Trinitrate CR 2 point 6 mg, Tab , TAB PIRACETAM 800 MG , Quitiapine 50 mg, Tab , Risperidone 4 mg Tab , Bethanechol 25mg Tab , Tab Tadalafil 10 mg , Mebeverine HCl 135mg Tab , Common Cold Tab Cetrizine 5 mg plus Paracetamol 500 mg plus Pseudoephdrine 60 mg , Tab Fenofibrate 160 mg , Moxifloxacin Hcl 0 point5 percent plus Dexamethasone 0 point 1 percent ophthalmic soln bott of 5 ml , E slace D Brinzolamide 1 percent , Brimonidine 0 point 2 percent plus Timolal eye drops, bott of 5 ml , Formeterol 20 mcg plus budesonide 0 point 5 mg respules , Human Insulin Analogue Glargine Inj, 100 IU slace ml Recombinant DNA origin 300IU Disposable Pen with 5 needles per pen , Tab Bisoprolol 5mg , Chloridiazepoxide 10 mg Tab , Tab Cilnidipine 5 mg , Glipizide 5 mg Tab , Clobazam 5 mg Tab , Fludrocortisone 0 point 1mg Tab , Tab Mirabegron 50 mg , Tab Voglibose 0 point 3 mg , Tab Rosuvastatin 10 mg , TAB ZIPRASIDONE 20 MG , Tab Midodrine 2 point 5mg , Tab Dutasteride 0 point 5 mg , Tab Clotrimazole 100 mg Vaginal Pessary , Tab Donepezil 10mg , Tab Methotrexate 15 mg , Tab Melatonin 3 mg , Fluconazole 0 point3 percent wslace v bott of 5 ml , Rizatriptan 5 mg Tab , Timolol Maleate 0 point 5 percent Preservative Free with Comod System , Tab Primidone 250 MG , Chloramphenicol 5 percent w slace v Clotrimazole 1 percent w slace v Betamethasone 0 point 25 percent wslace v Lignocaine HCL 2percent w slace v in bott of 5 ml , Cough Lozenges , Fluoxetine HCl 20 mg Cap , Tamsulosin 0 point 4mg and Dutasteride 0 point 5mg combination Cap slaceTab , Amlodipine 10 mg Tab , Alprazolam 0 point 5 Mg Tab , Dimethyl Fumarate 240 mg delayed release Capsules containing microteblets , Isosorbide Mononitrate 20 mg Tab , Tab Levetiracetam 250mg
May 3, 2025
May 24, 2025 at 1:00 PM
View Details

SYP CREMAFFIN WHITE EACH 15 ML CONTAINING MILK OF MAGNESIA 11 point 25 ML LIQ PARAFFIN 3 point 75 M

GEM
Goods
Qty:10.8L
4 Files
Indian Army
HYDERABAD, TELANGANA
Boq › Boql
SYP CREMAFFIN WHITE EACH 15 ML CONTAINING MILK OF MAGNESIA 11 point 25 ML LIQ PARAFFIN 3 point 75 ML BOTT OF 170 ML , CAP TAMSULOSIN HCL 0 point 4 MG , TAB RANOLAZINE 500 MG , TAB TICAGRELOR 90MG , TAB SITAGLIPTIN PHOSPHATE 50 MG , TAB SITAGLIPTIN 50 MG METFORMIN 1000 MG , TAB RABEPRAZOLE 20 MG , TAB URSODEOXYCHOLIC ACID 300MG , CAP CALCIUM CARBONATE 500 MG CALCITRIOL 0 point 25 MCG VIT K2 7 50 MCG ZINC 7 point 5 MG MAGNESIUM 50 MG , Bilastine 20mg Montelukast 10mg Tab , INJ HUMAN INSULIN LISPRO 50 per 50 100IU per ML , INSULIN ACTRAPID 30 per 70 , DIABETIC PROTEIN POWDER , INHALER SALMETEROL 25 MCG FLUTICASONE PROPIONATE 250 MCG , TAB ESOMEPRAZOLE 40 MG , Tab Orofer XT , TAB CANAGLIFLOZIN 100MG , TAB ROSUVASTATIN 20 MG , TAB ESOMEPRAZOLE40 MG LEVOSULPRIDE 75MG , TAB ATORVASTATIN 40 MG , TAB GABAPENTIN 300 MG METHYLCOBALAMINE 0 point 5 MG ALPHA LIPOLICACID 100 MG , TAB RASAGILINE 1 MG , TAB CEFPODOXIME 200 MG CLAVULANIC ACID 125 MG , TAB VALSARTAN 160 MG , TAB GABAPENTIN 400 MG NORTRYPTILLIN 10 MG , CAP ALPHALIPOLIC ACID VIT D3 VIT B COMPLEX , CAP CALCIUM CARBONATE SOFT GEL , TAB CHONDROITIN SULPHATE 200 MG COLLAGEN PEPTIDE40 MG SODIUM HYALURONATE 30 MG VIT C 35 MG , TAB COMMON COLD ANTIHISTAMINICS PARACETAMOL 500 MG WITHOUT PSEUDO EPHEDRINE , TAB NEPHROCAPS , TAB ETODOLAC 600 MG , TAB EVOGLIPTIN 5 MG , Tab Olmesartan 40mg Chlorthalidone 12 point 5mg
May 3, 2025
May 24, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, compliant with applicable regulations, and having demonstrated experience in supplying pharmaceuticals. It is essential that all potential bidders obtain relevant licenses and certifications to ensure adherence to quality and safety standards mandated by the authorities.

Bidders must provide required certificates demonstrating compliance with quality and industry standards, including but not limited to GMP (Good Manufacturing Practices), WHO prequalification, and any additional regulatory approvals mandated for selling drugs in government sectors.

The registration process involves creating an account on the designated government bidding portal. Interested bidders must follow the specific instructions available on the site, ensuring they complete all necessary steps to validate their participation in the tender.

Bidders are required to meet specific technical specifications for each pharmaceutical product, ensuring compliance with safety and quality standards. Detailed descriptions and requirements will be provided in the bidding documents, including testing protocols that validate the efficacy of products supplied.

The payment terms will be defined upon successful bid acceptance and typically involve milestone payments based on deliverables. Additionally, bidders must submit an Earnest Money Deposit (EMD) as part of their proposal, which will be outlined in the tender submission documents.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders